Prelude Therapeutics

Prelude was founded in 2016 with the vision of combining the energy and collaborative culture of a startup environment with the experience of developing cancer drugs to create the next generation of precision oncology companies. Prelude has assembled an experienced management team and board with deep expertise in oncology and drug development. We have built our internal discovery engine "from the ground up," led by scientific and medical teams with a proven ability to invent and rapidly develop small molecule drugs that have the potential to transform cancer treatment.